Jefferson Laboratory of Cognitive Aging

Are you concerned about your memory

or the memory of a loved one?

Complete our online survey to find out if you are eligible for one of our memory studies by clicking here.


The Laboratory of Dr. Angela Jefferson...

Discovering mechanisms and early diagnostic markers for unhealthy cognitive aging

Welcome to the website for the laboratory of Dr. Angela Jefferson. Our research focuses on discovering underlying mechanisms for unhealthy cognitive changes in older adults, such as mild cognitive impairment, for the purpose of informing prevention and therapeutic targets. 

Mild cognitive impairment is characterized by mild memory and cognitive changes among older adults. Scientists believe mild cognitive impairment is a very early stage of Alzheimer’s disease. Alzheimer’s disease is a major public health issue and affects over 5 million Americans.

If the scientific community is unable to find an effective prevention or treatment approach soon, the number of individuals over age 65 who are affected by Alzheimer’s disease may exceed 13 million by 2050. Therefore, research to advance prevention, diagnosis, and treatment of mild cognitive impairment and Alzheimer’s disease is critically important to minimize this growing public health burden.

Click here to learn how to help.

This page was last updated September 17, 2012 and is maintained by